(Q36856960)

16 August 2017

1 reference

title

Structure and function of the HIV envelope glycoprotein as entry mediator, vaccine immunogen, and target for inhibitors (English)

1 reference

16 August 2017

Ponraj Prabakaran

1

1 reference

16 August 2017

Antony S Dimitrov

series ordinal

2

1 reference

16 August 2017

Timothy R Fouts

series ordinal

3

1 reference

16 August 2017

Dimiter S Dimitrov

series ordinal

4

1 reference

16 August 2017

publication date

1 January 2007

1 reference

16 August 2017

published in

Advances in Pharmacology

1 reference

16 August 2017

volume

55

1 reference

16 August 2017

page(s)

33-97

1 reference

Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies.

16 August 2017

cites work

1 reference

12 December 2020

Prevention of HIV-2 and SIVsm infection by passive immunization in cynomolgus monkeys

1 reference

12 December 2020

Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody

1 reference

12 December 2020

Passive immunization of newborn rhesus macaques prevents oral simian immunodeficiency virus infection

1 reference

12 December 2020

HIV vaccine design and the neutralizing antibody problem

1 reference

12 December 2020

HIV-1 coreceptors and their inhibitors

2 references

12 December 2020

Crossref

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955002-7

7 January 2021

inferred from DOI database lookup

Assorted mutations in the envelope gene of simian immunodeficiency virus lead to loss of neutralization resistance against antibodies representing a broad spectrum of specificities

1 reference

12 December 2020

CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5.

1 reference

12 December 2020

HIV-1 entry and its inhibition

1 reference

12 December 2020

Virus entry: molecular mechanisms and biomedical applications

1 reference

12 December 2020

Covalently crosslinked complexes of human immunodeficiency virus type 1 (HIV-1) gp120 and CD4 receptor elicit a neutralizing immune response that includes antibodies selective for primary virus isolates

1 reference

12 December 2020

Expression and coreceptor function of APJ for primate immunodeficiency viruses

1 reference

12 December 2020

Specific interaction of CXCR4 with CD4 and CD8alpha: functional analysis of the CD4/CXCR4 interaction in the context of HIV-1 envelope glycoprotein-mediated membrane fusion

1 reference

12 December 2020

Induction of neutralizing antibody against human immunodeficiency virus type 1 (HIV-1) by immunization with gp41 membrane-proximal external region (MPER) fused with porcine endogenous retrovirus (PERV) p15E fragment

1 reference

12 December 2020

Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1

2 references

12 December 2020

Crossref

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955002-7

7 January 2021

inferred from DOI database lookup

Selection of a novel gp41-specific HIV-1 neutralizing human antibody by competitive antigen panning

1 reference

12 December 2020

Coreceptor specificity of temporal variants of simian immunodeficiency virus Mne.

1 reference

12 December 2020

HIV vaccine design: insights from live attenuated SIV vaccines

1 reference

12 December 2020

HIV-1 gp41 envelope residues 650-685 exposed on native virus act as a lectin to bind epithelial cell galactosyl ceramide

1 reference

12 December 2020

Molecular characteristics of recombinant human CD4 as deduced from polymorphic crystals

1 reference

12 December 2020

A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1

1 reference

12 December 2020

Increased efficacy of HIV-1 neutralization by antibodies at low CCR5 surface concentration.

1 reference

12 December 2020

Phase I Study of a Human Monoclonal Antibody Directed against the CD4-Binding Site of HIV Type 1 Glycoprotein 120

1 reference

12 December 2020

Separation of functional subsets of human T cells by a monoclonal antibody

1 reference

12 December 2020

Homotypic antibody responses to fresh clinical isolates of human immunodeficiency virus

1 reference

12 December 2020

Clinical trials of HIV vaccines.

1 reference

12 December 2020

Promoting trimerization of soluble human immunodeficiency virus type 1 (HIV-1) Env through the use of HIV-1/simian immunodeficiency virus chimeras

1 reference

12 December 2020

The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus

1 reference

12 December 2020

Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection

1 reference

12 December 2020

The SIV surface spike imaged by electron tomography: one leg or three?

1 reference

12 December 2020

A simplified method for the rapid fluorometric assessment of antibody-dependent cell-mediated cytotoxicity.

1 reference

12 December 2020

Characterization of stable, soluble trimers containing complete ectodomains of human immunodeficiency virus type 1 envelope glycoproteins

1 reference

12 December 2020

Yet another subtype of HIV type 1?

1 reference

12 December 2020

Modulation of entry of enveloped viruses by cholesterol and sphingolipids (Review).

1 reference

12 December 2020

Monoclonal antibody cure and prophylaxis of lethal Sindbis virus encephalitis in mice

1 reference

12 December 2020

Purification and characterization of oligomeric envelope glycoprotein from a primary R5 subtype B human immunodeficiency virus

1 reference

12 December 2020

Inhibition of Entry of HIV-1 in Neural Cell Lines by Antibodies Against Galactosyl Ceramide

1 reference

12 December 2020

Rapid evolution of the neutralizing antibody response to HIV type 1 infection

1 reference

12 December 2020

Molecular features of the broadly neutralizing immunoglobulin G1 b12 required for recognition of human immunodeficiency virus type 1 gp120.

1 reference

12 December 2020

Efficient inhibition of HIV-1 replication in human immature monocyte-derived dendritic cells by purified anti-HIV-1 IgG without induction of maturation

1 reference

12 December 2020

Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies.

1 reference

12 December 2020

Constitutive cell surface association between CD4 and CCR5.

1 reference

12 December 2020

Scorpion-toxin mimics of CD4 in complex with human immunodeficiency virus gp120 crystal structures, molecular mimicry, and neutralization breadth

1 reference

12 December 2020

Postnatal pre- and postexposure passive immunization strategies: protection of neonatal macaques against oral simian-human immunodeficiency virus challenge

1 reference

12 December 2020

Monoclonal antibodies raised against covalently crosslinked complexes of human immunodeficiency virus type 1 gp120 and CD4 receptor identify a novel complex-dependent epitope on gp 120.

1 reference

12 December 2020

Nonneutralizing antibodies are able to inhibit human immunodeficiency virus type 1 replication in macrophages and immature dendritic cells

1 reference

12 December 2020

Analysis of cell surfaces by xenogeneic myeloma-hybrid antibodies: Differentiation antigens of rat lymphocytes

1 reference

12 December 2020

Human immunodeficiency virus type 2

1 reference

12 December 2020

Genetic and biological comparisons of pathogenic and nonpathogenic molecular clones of simian immunodeficiency virus (SIVmac).

1 reference

12 December 2020

A longitudinal study of neutralizing antibodies and disease progression in HIV-1-infected subjects

1 reference

12 December 2020

High throughput screening and characterization of HIV-1 entry inhibitors targeting gp41: theories and techniques

1 reference

12 December 2020

Antibody-dependent cellular cytotoxicity in HIV infections.

1 reference

12 December 2020

Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission

1 reference

12 December 2020

Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1

1 reference

12 December 2020

HIV-1 envelope proteins complete their folding into six-helix bundles immediately after fusion pore formation

1 reference

12 December 2020

HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites

1 reference

12 December 2020

Kinetics of soluble CD4 binding to cells expressing human immunodeficiency virus type 1 envelope glycoprotein

1 reference

12 December 2020

A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1.

1 reference

12 December 2020

Antibodies, viruses and vaccines

1 reference

12 December 2020

Soluble mimetics of human immunodeficiency virus type 1 viral spikes produced by replacement of the native trimerization domain with a heterologous trimerization motif: characterization and ligand binding analysis

1 reference

12 December 2020

Long-lasting CCR5 internalization by antibodies in a subset of long-term nonprogressors: a possible protective effect against disease progression

1 reference

12 December 2020

The clinical potential of sphingolipid-based therapeutics

1 reference

12 December 2020

Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes

1 reference

12 December 2020

Fine mapping of the interaction of neutralizing and nonneutralizing monoclonal antibodies with the CD4 binding site of human immunodeficiency virus type 1 gp120.

1 reference

12 December 2020

A general model for the surface glycoproteins of HIV and other retroviruses.

1 reference

12 December 2020

How do viruses enter cells? The HIV coreceptors teach us a lesson of complexity

1 reference

12 December 2020

Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody

1 reference

12 December 2020

Neutralization escape in human immunodeficiency virus type 1-infected long-term nonprogressors

1 reference

12 December 2020

Current progress in the development of HIV vaccines

1 reference

12 December 2020

A general model for the transmembrane proteins of HIV and other retroviruses

1 reference

12 December 2020

The rational design of an AIDS vaccine

1 reference

12 December 2020

Vaccine-elicited antibodies mediate antibody-dependent cellular cytotoxicity correlated with significantly reduced acute viremia in rhesus macaques challenged with SIVmac251

1 reference

12 December 2020

Prevention of HIV infection by passive immunization with HIVIG or CD4-IgG

1 reference

12 December 2020

The emergence of simian/human immunodeficiency viruses

1 reference

12 December 2020

Multiple nonfunctional alleles of CCR5 are frequent in various human populations

1 reference

12 December 2020

Crystal structure of the broadly cross-reactive HIV-1-neutralizing Fab X5 and fine mapping of its epitope

1 reference

12 December 2020

Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41.

1 reference

12 December 2020

HIV vaccines: new frontiers in vaccine development

1 reference

12 December 2020

Prospects for an AIDS vaccine: three big questions, no easy answers.

1 reference

12 December 2020

Antibody raised against soluble CD4-rgp120 complex recognizes the CD4 moiety and blocks membrane fusion without inhibiting CD4-gp120 binding

1 reference

12 December 2020

Dimeric association and segmental variability in the structure of human CD4

1 reference

12 December 2020

Mutagenic stabilization and/or disruption of a CD4-bound state reveals distinct conformations of the human immunodeficiency virus type 1 gp120 envelope glycoprotein

1 reference

12 December 2020

Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS.

1 reference

12 December 2020

Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera.

1 reference

12 December 2020

Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1.

1 reference

12 December 2020

Core structure of gp41 from the HIV envelope glycoprotein

1 reference

12 December 2020

The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens

1 reference

12 December 2020

Antibodies: can they protect against HIV infection?

1 reference

12 December 2020

HIV-1 entry inhibitors in the side pocket

1 reference

12 December 2020

gp120: Biologic aspects of structural features

1 reference

12 December 2020

The antibody response in HIV-1 infection.

1 reference

12 December 2020

Antibody-based inhibitors of HIV infection

1 reference

12 December 2020

Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains

1 reference

12 December 2020

A trimeric structural domain of the HIV-1 transmembrane glycoprotein.

1 reference

12 December 2020

Identification of a new human immunodeficiency virus type 1 distinct from group M and group O.

1 reference

12 December 2020

Broadly cross-reactive HIV neutralizing human monoclonal antibody Fab selected by sequential antigen panning of a phage display library

1 reference

12 December 2020

The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120.

1 reference

12 December 2020

Evaluation of envelope vaccines derived from the South African subtype C human immunodeficiency virus type 1 TV1 strain

1 reference

12 December 2020

Chemokine receptor CCR5: polymorphism at protein level

1 reference

12 December 2020

Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies

1 reference

12 December 2020

The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120.

1 reference

12 December 2020

HIV-1 gp120 chemokine receptor-mediated signaling in human macrophages

1 reference

12 December 2020

Structural mimicry of CD4 by a cross-reactive HIV-1 neutralizing antibody with CDR-H2 and H3 containing unique motifs.

1 reference

12 December 2020

The membrane-proximal external region of HIV-1 gp41: a vaccine target worth exploring

1 reference

12 December 2020

Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection

1 reference

12 December 2020

Identification and characterization of a new cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody

1 reference

12 December 2020

Expression and characterization of a single-chain polypeptide analogue of the human immunodeficiency virus type 1 gp120-CD4 receptor complex

1 reference

12 December 2020

HIV vaccine development

1 reference

12 December 2020

CD4-independent infection by HIV-2 is mediated by fusin/CXCR4.

1 reference

12 December 2020

Small-molecule HIV-1 gp120 inhibitors to prevent HIV-1 entry: an emerging opportunity for drug development.

1 reference

12 December 2020

HIV-1 gp41: mediator of fusion and target for inhibition

1 reference

12 December 2020

Expression of multiple functional chemokine receptors and monocyte chemoattractant protein-1 in human neurons

1 reference

12 December 2020

How Viruses Enter Animal Cells

1 reference

12 December 2020

Evidence for CD4-enchanced signaling through the chemokine receptor CCR5

1 reference

12 December 2020

Viral persistence: HIV's strategies of immune system evasion

1 reference

12 December 2020

Involvement of Fc gamma RI (CD64) in the mechanism of HIV-1 inhibition by polyclonal IgG purified from infected patients in cultured monocyte-derived macrophages

1 reference

12 December 2020

Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors

1 reference

12 December 2020

Cryo-electron tomographic structure of an immunodeficiency virus envelope complex in situ

1 reference

12 December 2020

Identification of gp120 binding sites on CXCR4 by using CD4-independent human immunodeficiency virus type 2 Env proteins

1 reference

12 December 2020

Kinetic factors control efficiencies of cell entry, efficacies of entry inhibitors, and mechanisms of adaptation of human immunodeficiency virus

1 reference

12 December 2020

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

1 reference

12 December 2020

Conformational changes in HIV-1 gp41 in the course of HIV-1 envelope glycoprotein-mediated fusion and inactivation.

1 reference

12 December 2020

A spring-loaded mechanism for the conformational change of influenza hemagglutinin

1 reference

12 December 2020

Quintuple deglycosylation mutant of simian immunodeficiency virus SIVmac239 in rhesus macaques: robust primary replication, tightly contained chronic infection, and elicitation of potent immunity against the parental wild-type strain

1 reference

12 December 2020

Structural definition of a conserved neutralization epitope on HIV-1 gp120

1 reference

12 December 2020

Interplay of HIV-1 phenotype and neutralizing antibody response in pathogenesis of AIDS

1 reference

12 December 2020

A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure

1 reference

12 December 2020

Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease

1 reference

12 December 2020

Evolution of HIV-1 coreceptor usage through interactions with distinct CCR5 and CXCR4 domains

1 reference

12 December 2020

Multiple extracellular elements of CCR5 and HIV-1 entry: dissociation from response to chemokines

1 reference

12 December 2020

A variable region 3 (V3) mutation determines a global neutralization phenotype and CD4-independent infectivity of a human immunodeficiency virus type 1 envelope associated with a broadly cross-reactive, primary virus-neutralizing antibody response

1 reference

12 December 2020

Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1.

1 reference

12 December 2020

Antigenic conservation and immunogenicity of the HIV coreceptor binding site

1 reference

12 December 2020

Immunization with a soluble CD4-gp120 complex preferentially induces neutralizing anti-human immunodeficiency virus type 1 antibodies directed to conformation-dependent epitopes of gp120.

1 reference

12 December 2020

Postnatal passive immunization of neonatal macaques with a triple combination of human monoclonal antibodies against oral simian-human immunodeficiency virus challenge

1 reference

12 December 2020

Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro

1 reference

12 December 2020

Evaluating the immunogenicity of a disulfide-stabilized, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1

1 reference

12 December 2020

Expression and coreceptor activity of STRL33/Bonzo on primary peripheral blood lymphocytes

1 reference

12 December 2020

DNA vaccines expressing soluble CD4-envelope proteins fused to C3d elicit cross-reactive neutralizing antibodies to HIV-1.

1 reference

12 December 2020

An N-glycan within the human immunodeficiency virus type 1 gp120 V3 loop affects virus neutralization

1 reference

12 December 2020

Preparation and characterization of human HIV type 1 neutralizing reference sera

1 reference

12 December 2020

Neutralization of the human immunodeficiency virus type 1 primary isolate JR-FL by human monoclonal antibodies correlates with antibody binding to the oligomeric form of the envelope glycoprotein complex

1 reference

12 December 2020

Dissection of human immunodeficiency virus type 1 entry with neutralizing antibodies to gp41 fusion intermediates

1 reference

12 December 2020

Longitudinal studies of viral sequence, viral phenotype, and immunologic parameters of human immunodeficiency virus type 1 infection in perinatally infected twins with discordant disease courses

1 reference

12 December 2020

Electron tomography analysis of envelope glycoprotein trimers on HIV and simian immunodeficiency virus virions

1 reference

12 December 2020

Natural controlled HIV infection: preserved HIV-specific immunity despite undetectable replication competent virus

1 reference

12 December 2020

1 reference

12 December 2020

Post-exposure prophylaxis with human monoclonal antibodies prevented SHIV89.6P infection or disease in neonatal macaques

1 reference

12 December 2020

Corrected CD4 sequence

1 reference

12 December 2020

Antibody vs. HIV in a clash of evolutionary titans

1 reference

12 December 2020

Progress toward an HIV vaccine

1 reference

12 December 2020

Fundamental immunology and what it can teach us about HIV vaccine development

1 reference

12 December 2020

Importance of B-cell responses for immunological control of variant strains of simian immunodeficiency virus

1 reference

12 December 2020

Structure of influenza haemagglutinin at the pH of membrane fusion

1 reference

12 December 2020

The isolation and nucleotide sequence of a cDNA encoding the T cell surface protein T4: a new member of the immunoglobulin gene family

1 reference

12 December 2020

Relationship between antibody-dependent cellular cytotoxicity, plasma HIV type 1 RNA, and CD4+ lymphocyte count.

1 reference

12 December 2020

Marked structural and functional heterogeneity in CXCR4: separation of HIV-1 and SDF-1alpha responses

1 reference

12 December 2020

Expression and characterization of HIV type 1 envelope protein associated with a broadly reactive neutralizing antibody response

1 reference

12 December 2020

Cellular immunity elicited by human immunodeficiency virus type 1/ simian immunodeficiency virus DNA vaccination does not augment the sterile protection afforded by passive infusion of neutralizing antibodies

1 reference

12 December 2020

Sustained antibody-dependent cell-mediated cytotoxicity (ADCC) in SIV-infected macaques correlates with delayed progression to AIDS

1 reference

12 December 2020

CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5.

1 reference

12 December 2020

HIV binding to its receptor creates specific epitopes for the CD4/gp120 complex

1 reference

12 December 2020

The neutralizing antibody response to HIV-1: viral evasion and escape from humoral immunity

1 reference

12 December 2020

Toward oligosaccharide- and glycopeptide-based HIV vaccines.

1 reference

12 December 2020

Recent advances in understanding the molecular mechanisms of HIV-1 entry and fusion: revisiting current targets and considering new options for therapeutic intervention

1 reference

12 December 2020

Identifying epitopes of HIV-1 that induce protective antibodies

1 reference

12 December 2020

Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope

1 reference

12 December 2020

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

1 reference

12 December 2020

The antiviral activity of antibodies in vitro and in vivo.

1 reference

12 December 2020

Atomic structure of the ectodomain from HIV-1 gp41

1 reference

12 December 2020

Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes

1 reference

12 December 2020

Augmented serum neutralizing activity against primary human immunodeficiency virus type 1 (HIV-1) isolates in two groups of HIV-1-infected long-term nonprogressors

1 reference

12 December 2020

Antibody polyspecificity and neutralization of HIV-1: a hypothesis

1 reference

12 December 2020

Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection

1 reference

12 December 2020

Emerging anti-HIV drugs

1 reference

12 December 2020

A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon

1 reference

12 December 2020

Advances in HIV-1 entry inhibitors: strategies to interfere with receptor and coreceptor engagement

1 reference

12 December 2020

Protection of neonatal macaques against experimental SHIV infection by human neutralizing monoclonal antibodies

1 reference

12 December 2020

Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion

1 reference

12 December 2020

HIV entry and its inhibition

1 reference

12 December 2020

Anti-CD4-binding domain antibodies complexed with HIV type 1 glycoprotein 120 inhibit CD4+ T cell-proliferative responses to glycoprotein 120.

1 reference

12 December 2020

Determination of the protective epitopes on the glycoproteins of Venezuelan equine encephalomyelitis virus by passive transfer of monoclonal antibodies

1 reference

12 December 2020

Evidence for cell-surface association between fusin and the CD4-gp120 complex in human cell lines

1 reference

12 December 2020

Antibody-dependent cellular cytotoxicity independently predicts survival in severely immunocompromised human immunodeficiency virus-infected patients

1 reference

12 December 2020

Structure of the Fab fragment of F105, a broadly reactive anti-human immunodeficiency virus (HIV) antibody that recognizes the CD4 binding site of HIV type 1 gp120.

1 reference

12 December 2020

Humoral immune response to immunocomplexed HIV envelope glycoprotein 120.

1 reference

12 December 2020

HIV-1 gp41 as a target for viral entry inhibition

1 reference

12 December 2020

CD4-independent association between HIV-1 gp120 and CXCR4: functional chemokine receptors are expressed in human neurons

1 reference

12 December 2020

Emerging cytopathic and antigenic simian immunodeficiency virus variants influence AIDS progression.

1 reference

12 December 2020

Antibody neutralization and escape by HIV-1

1 reference

12 December 2020

Determination of a statistically valid neutralization titer in plasma that confers protection against simian-human immunodeficiency virus challenge following passive transfer of high-titered neutralizing antibodies

1 reference

12 December 2020

Rational engineering of a miniprotein that reproduces the core of the CD4 site interacting with HIV-1 envelope glycoprotein

1 reference

12 December 2020

Conformational changes of gp120 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic

1 reference

12 December 2020

Retrovirus envelope domain at 1.7 angstrom resolution

1 reference

12 December 2020

Characterization of CD4-induced epitopes on the HIV type 1 gp120 envelope glycoprotein recognized by neutralizing human monoclonal antibodies

1 reference

12 December 2020

Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein

1 reference

12 December 2020

Current advances in HIV vaccines

1 reference

12 December 2020

Structure-based, targeted deglycosylation of HIV-1 gp120 and effects on neutralization sensitivity and antibody recognition.

1 reference

12 December 2020

Highly stable trimers formed by human immunodeficiency virus type 1 envelope glycoproteins fused with the trimeric motif of T4 bacteriophage fibritin

1 reference

12 December 2020

Specific N-linked and O-linked glycosylation modifications in the envelope V1 domain of simian immunodeficiency virus variants that evolve in the host alter recognition by neutralizing antibodies

1 reference

12 December 2020

Generation of a neutralization-resistant variant of HIV-1 is due to selection for a point mutation in the envelope gene.

1 reference

12 December 2020

1 reference

12 December 2020

Synthesis of novel, multivalent glycodendrimers as ligands for HIV-1 gp120.

1 reference

12 December 2020

Role of N-linked glycans in a human immunodeficiency virus envelope glycoprotein: effects on protein function and the neutralizing antibody response

1 reference

12 December 2020

HIV-Specific Antibodies But Not T-Cell Responses Are Associated With Protection in Seronegative Partners of HIV-1-Infected Individuals in Cambodia

1 reference

12 December 2020

Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design

1 reference

12 December 2020

Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1.

1 reference

12 December 2020

Regions in beta-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity

1 reference

12 December 2020

Complete protection of neonatal rhesus macaques against oral exposure to pathogenic simian-human immunodeficiency virus by human anti-HIV monoclonal antibodies

1 reference

12 December 2020

HIV vaccines: brief review and discussion of future directions.

1 reference

12 December 2020

Neutralizing antibody responses to HIV: role in protective immunity and challenges for vaccine design.

1 reference

12 December 2020

Role of the amino-terminal extracellular domain of CXCR-4 in human immunodeficiency virus type 1 entry

1 reference

12 December 2020

Crystal structure of an extracellular fragment of the rat CD4 receptor containing domains 3 and 4

1 reference

12 December 2020

The cytomegalovirus-encoded chemokine receptor US28 can enhance cell-cell fusion mediated by different viral proteins

1 reference

12 December 2020

Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences

1 reference

12 December 2020

Effects of antibody on viral kinetics in simian/human immunodeficiency virus infection: implications for vaccination

1 reference

12 December 2020

Autologous HIV-1 neutralizing antibodies: emergence of neutralization-resistant escape virus and subsequent development of escape virus neutralizing antibodies

1 reference

12 December 2020

Characterization of antibodies that inhibit HIV gp120 antigen processing and presentation

1 reference

12 December 2020

A role for carbohydrates in immune evasion in AIDS.

1 reference

12 December 2020

Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120

1 reference

12 December 2020

Protection against lethal viral infection by neutralizing and nonneutralizing monoclonal antibodies: distinct mechanisms of action in vivo

1 reference

12 December 2020

Structure of a V3-containing HIV-1 gp120 core

1 reference

12 December 2020

Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates

1 reference

12 December 2020

Characterization of the outer domain of the gp120 glycoprotein from human immunodeficiency virus type 1

1 reference

12 December 2020

Passive immunization against oral AIDS virus transmission: an approach to prevent mother-to-infant HIV-1 transmission?

1 reference

12 December 2020

Tyrosine sulfation of human antibodies contributes to recognition of the CCR5 binding region of HIV-1 gp120.

1 reference

12 December 2020

Increased neutralization sensitivity of CD4-independent human immunodeficiency virus variants

1 reference

12 December 2020

Fusin--a place for HIV-1 and T4 cells to meet

1 reference

12 December 2020

Expression, purification, and characterization of recombinant HIV gp140. The gp41 ectodomain of HIV or simian immunodeficiency virus is sufficient to maintain the retroviral envelope glycoprotein as a trimer

1 reference

12 December 2020

Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41

1 reference

12 December 2020

Rational design of a CD4 mimic that inhibits HIV-1 entry and exposes cryptic neutralization epitopes

1 reference

12 December 2020

Analysis of the immunogenic properties of a single-chain polypeptide analogue of the HIV-1 gp120?CD4 complex in transgenic mice that produce human immunoglobulins

1 reference

12 December 2020

HIV and the 7-transmembrane domain receptors

1 reference

12 December 2020

Novel approaches for identification of broadly cross-reactive HIV-1 neutralizing human monoclonal antibodies and improvement of their potency

1 reference

12 December 2020

Immune escape by human immunodeficiency virus type 1 from neutralizing antibodies: evidence for multiple pathways.

1 reference

12 December 2020

Crystal structure of the simian immunodeficiency virus (SIV) gp41 core: conserved helical interactions underlie the broad inhibitory activity of gp41 peptides

1 reference

12 December 2020

Inhibition of human immunodeficiency virus type 1 gp120 presentation to CD4 T cells by antibodies specific for the CD4 binding domain of gp120

1 reference

12 December 2020

Crosslinked HIV-1 envelope-CD4 receptor complexes elicit broadly cross-reactive neutralizing antibodies in rhesus macaques

1 reference

12 December 2020

Retrovirus envelope glycoproteins

1 reference

12 December 2020

The HIV Env-mediated fusion reaction

1 reference

12 December 2020

HIV-1 entry inhibitors: new targets, novel therapies

1 reference

12 December 2020

Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding

1 reference

12 December 2020

Critical role for Env as well as Gag-Pol in control of a simian-human immunodeficiency virus 89.6P challenge by a DNA prime/recombinant modified vaccinia virus Ankara vaccine

1 reference

12 December 2020

Lateral diffusion of CD4 on the surface of a human neoplastic T-cell line probed with a fluorescent derivative of the envelope glycoprotein (gp120) of human immunodeficiency virus type 1 (HIV-1).

1 reference

12 December 2020

Subunit Protein Vaccines: Theoretical and Practical Considerations for HIV-1

1 reference

12 December 2020

T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV

1 reference

12 December 2020

A replication-competent, neutralization-sensitive variant of simian immunodeficiency virus lacking 100 amino acids of envelope

1 reference

12 December 2020

Prevention of HIV-1 infection in chimpanzees by gpl20 V3 domain-specific monoclonal antibody

1 reference

12 December 2020

Neutralization of diverse human immunodeficiency virus type 1 variants by an anti-V3 human monoclonal antibody

1 reference

12 December 2020

Fusion of monocytes and macrophages with HIV-1 correlates with biochemical properties of CXCR4 and CCR5.

1 reference

12 December 2020

Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys

1 reference

12 December 2020

Structural characteristics correlate with immune responses induced by HIV envelope glycoprotein vaccines

1 reference

12 December 2020

Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies

1 reference

12 December 2020

Retrovirus envelope protein complex structure in situ studied by cryo-electron tomography

1 reference

12 December 2020

Distribution and three-dimensional structure of AIDS virus envelope spikes

1 reference

12 December 2020

The differentiation and function of human T lymphocytes

1 reference

12 December 2020

Immunogenicity of constrained monoclonal antibody A32-human immunodeficiency virus (HIV) Env gp120 complexes compared to that of recombinant HIV type 1 gp120 envelope glycoproteins

1 reference

12 December 2020

Genetic and phylogenetic analysis of env subtypes G and H in central Africa

1 reference

12 December 2020

Use of monoclonal antibody directed against herpes simplex virus glycoproteins to protect mice against acute virus-induced neurological disease

1 reference

12 December 2020

Evidence for a correlation between antibody-dependent cellular cytotoxicity-mediating anti-HIV-1 antibodies and prognostic predictors of HIV infection

1 reference

12 December 2020

CD4 independence of simian immunodeficiency virus Envs is associated with macrophage tropism, neutralization sensitivity, and attenuated pathogenicity

1 reference

12 December 2020

Crystal structure of an HIV-binding recombinant fragment of human CD4.

1 reference

12 December 2020

Comparing antigenicity and immunogenicity of engineered gp120.

1 reference

12 December 2020

Characterization of gp120 and its single-chain derivatives, gp120-CD4D12 and gp120-M9: implications for targeting the CD4i epitope in human immunodeficiency virus vaccine design

1 reference

12 December 2020

Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys.

1 reference

12 December 2020

Distinct functional sites for human immunodeficiency virus type 1 and stromal cell-derived factor 1alpha on CXCR4 transmembrane helical domains

1 reference

12 December 2020

Two distinct CCR5 domains can mediate coreceptor usage by human immunodeficiency virus type 1.

1 reference

12 December 2020

Structure-function analysis of the epitope for 4E10, a broadly neutralizing human immunodeficiency virus type 1 antibody

1 reference

12 December 2020

Multiple interactions across the surface of the gp120 core structure determine the global neutralization resistance phenotype of human immunodeficiency virus type 1

1 reference

12 December 2020

Potent cross-group neutralization of primary human immunodeficiency virus isolates with monoclonal antibodies--implications for acquired immunodeficiency syndrome vaccine

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FS1054-3589%2807%2955002-7

7 January 2021

inferred from DOI database lookup

Cell biology. Korean team speeds up creation of cloned human stem cells.

1 reference

12 December 2020

10.1016/S1054-3589(07)55002-7

Identifiers

DOI

1 reference

16 August 2017

1 reference